Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
0(0%)
Results Posted
33%(3 trials)

Phase Distribution

Ph phase_3
3
30%
Ph phase_4
2
20%
Ph phase_2
2
20%
Ph phase_1
3
30%

Phase Distribution

3

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
3(30.0%)
Phase 2Efficacy & side effects
2(20.0%)
Phase 3Large-scale testing
3(30.0%)
Phase 4Post-market surveillance
2(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(9)
Other(1)

Detailed Status

Completed9
unknown1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (30.0%)
Phase 22 (20.0%)
Phase 33 (30.0%)
Phase 42 (20.0%)

Trials by Status

unknown110%
completed990%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
10